Dermata Therapeutics- Warrants (13/08/2026) Other Current Liabilities

Dermata Therapeutics- Warrants (13/08/2026) (DRMAW) currently reports a other current liabilities of $710K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Dermata Therapeutics- Warrants (13/08/2026)'s other current liabilities history and peer comparisons.

Dermata Therapeutics- Warrants (13/08/2026)'s other current liabilities changed from $0 to $710K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dermata Therapeutics- Warrants (13/08/2026) reported $710K in other current liabilities as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $710K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dermata Therapeutics- Warrants (13/08/2026), and consider following DRMAW for alerts when major investors trade the stock.

Dermata Therapeutics- Warrants (13/08/2026) is classified in the Healthcare sector. On other current liabilities, it currently shows $710K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRMAW with unrelated industries.